See the rest here: Vistin Pharma ASA: Invitation to Q3 2024 conference call
See the rest here: Vistin Pharma ASA: Invitation to Q3 2024 conference call
Read the original post: Innocan Pharma to Present at the 2024 ThinkEquity Conference
Read the original: Valneva to Present on Chikungunya at Several Leading Scientific Conferences
See the rest here: Responsibility statement for first half year of 2024
See original here: Oculis Accelerates Enrollment in both DIAMOND Phase 3 Trials of OCS-01 in Diabetic Macular Edema and Expands its DIAMOND Program Committees
View original post here: Nurix Therapeutics Announces Presentations at the 7th Annual TPD & Induced Proximity Summit
See the article here: Tevogen Bio Specialty Care Reports Top-Line Revenue Forecast of Nearly $1 Billion in Launch Year and Cumulative 5-Year Estimate Between $18 Billion...
Continue reading here: Revolution Medicines Announces First Patient Dosed in Phase 3 Study Evaluating RMC-6236 in Previously Treated Patients with Metastatic Pancreatic...
Recent Comments